Welcome to He Group!

Welcome to HE Group!

Research in the HE group is aimed at exploring the novel properties of nanomaterials for higher-performance renewable energy devices, trace level molecular detection and multifunctional nonviral gene delivery agents for cancer therapy.

• Conducting polymer/carbon nanotube (Graphene) composites

• Multiplexed electrical and optical biosensors

• Nanotechnology for nonviral gene delivery and co-delivery of multiple drugs for efficient cancer therapy

Latest News

Yufeng Ma won New Jersey Patent Award (2010). Congratulations!
Alex Minhua Chen was awarded Graduate School Dean's Doctoral Dissertation Award for his outstanding doctoral dissertation (2009). Congratulations!
Oleh Taratula Won The New Jersey Cancer Research Award for Scientific Excellence (2009). Congratulations!
On Jan. 20, 2009, Alex Minhua Chen successfully passed his Ph.D. Defense. Thesis title: Nanotechnology for Efficient Delivery of Short Therapeutic Oligonucleotides and Co-delivery with Chemical Anticancer Drugs for Effective Cancer Therapy. Congratulate Alex on his remarkable works!!! Alex returned to Merck & Co. for a full-time position!
In Sep, 2008, Oleh Taratula became No.2 Ph.D. in He Group after successfully defending his thesis titled: Nanotechnology in developing multifunctional non-viral gene delivery systems. Oleh joined Dr. Minko's group as postdoctoral associate in Oct, 2008.
In Aug, 2008, Shah R. Ali was accepted to Stanford Medical School. Congratulation on his great success and wish him the best in the future!
In Sept, 2007, Yufeng Ma successfully defended his thesis and became No.1 Ph.D. in He Group. Yufeng is now a senior scientist in Polyestar Tech., Boston, MA.